P D F - S E A R C H

Нашёл 793 ответа for 'Ecallantide'.

Ecallantide: Pediatric Medication
Ecallantide. Brand Names: US. Warning. You must check to make. Ecallantide. 1/5. sure that it is safe for your child to take this drug with all of his/her drug s and health problems.

https://www.mskcc.org/pdf/cancer-care/patient-education/ecallantide

Ecallantide for the treatment of acute attacks of hereditary
Ecallantide is a highly specific and potent plasma kallikrein inhibitor approved for the treatment of acute attacks of HAE-C1INH. In two randomized, placebo-controlled, Phase III clinical trials...

https://www.openaccessjournals.com/articles/ecallantide-for-the-treatment-of-acute-attacks-of-hereditary-angioedema-due-to-c1inhibitor-deficiency.pdf

Overview of ecallantide in the treatment of
Introduction to ecallantide Ecallantide is a potent and specific plasma kallikrein inhibitor that blocks generation of bradykinin. Pharmacodynamics Ecallantide delays thrombin generation in vitro [25].

https://www.openaccessjournals.com/articles/overview-of-ecallantide-in-the-treatment-of-hereditary-angioedema-types-i-and-ii.pdf

Clinical Policy: Ecallantide (Kalbitor
Description Ecallantide (Kalbitor®) is a plasma kallikrein inhibitor. FDA Approved Indication(s) Kalbitor is indicated for treatment of acute attacks of hereditary angioedema (HAE) in patients. 12 years of age...

https://www.buckeyehealthplan.com/content/dam/centene/policies/pharmacy-policies/CP.PHAR.177%20Ecallantide.pdf

KALBITOR® (ecallantide)
Active Ingredient: ecallantide. Inactive ingredients: disodium hydrogen orthophosphate (dihydrate), monopotassium phosphate, potassium chloride, sodium chloride in water for injection.

https://www.fda.gov/media/77784/download

Medication Guide
Active Ingredient: ecallantide. Inactive ingredients: disodium hydrogen orthophosphate (dihydrate), monopotassium phosphate, potassium chloride, sodium chloride in water for injection.

https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/125277MedGuide.pdf

CENTER FOR DRUG EVALUATION AND RESEARCH application nu
DX-88 (ecallantide). 1.14.1.3 Draft Label - KALBITOR? -DOSAGE FORMS AND STRENGTHS- Single use glass vial containing 10 mg/mL of ecallantide as a solution for injection.

https://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/125277s000Lbl.pdf

MG_Kalbitor_ecallantide.pdf
Kalbitor® (ecallantide). Last Review Date: October 14, 2019. Kalbitor (ecallantide) is considered medically necessary for the treatment of acute attacks of hereditary angioedema when the following...

https://www.emblemhealth.com/content/dam/emblemhealth/pdfs/provider/medical_policies/k/MG_Kalbitor_ecallantide.pdf

Kalbitor, INN-ecallantide
The ecallantide in Kalbitor is produced by a method known as ‘recombinant DNA technology’. This means that it is made by a cell that has received a gene (DNA), which makes the cell able to produce it.

https://www.ema.europa.eu/en/documents/medicine-qa/questions-answers-withdrawal-marketing-authorisation-application-kalbitor_en.pdf

Dyax s.a. withdraws its marketing authorisation application for Kalbitor...
The European Medicines Agency has been formally notified by Dyax s.a. of its decision to withdraw its application for a centralised marketing authorisation for the medicine Kalbitor (ecallantide), 10 mg/ml...

https://www.ema.europa.eu/en/documents/press-release/dyax-sa-withdraws-its-marketing-authorisation-application-kalbitor-ecallantide_en.pdf